Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Total Non-Current Liabilities (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $872.8 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Total Non-Current Liabilities rose 19.54% year-over-year to $872.8 million, compared with a TTM value of $872.8 million through Dec 2024, up 19.54%, and an annual FY2024 reading of $872.8 million, up 19.54% over the prior year.
  • Total Non-Current Liabilities was $872.8 million for Q4 2024 at Cresco Labs, up from $730.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $989.0 million in Q4 2022 and bottomed at -$762.6 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $446.8 million, with a median of $730.2 million recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities crashed 288.56% in 2021, then surged 229.7% in 2022.
  • Year by year, Total Non-Current Liabilities stood at $404.4 million in 2020, then plummeted by 288.56% to -$762.6 million in 2021, then soared by 229.7% to $989.0 million in 2022, then decreased by 26.17% to $730.2 million in 2023, then rose by 19.54% to $872.8 million in 2024.
  • Business Quant data shows Total Non-Current Liabilities for CRLBF at $872.8 million in Q4 2024, $730.2 million in Q4 2023, and $989.0 million in Q4 2022.